Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Loris De Cecco

Showing results (131-140 of 169) with videos related to

Pageof 17
Sort By:
Acta Oncologica (Stockholm, Sweden)|April 22, 2024
Gender Difference in sidE eFfects of ImmuNotherapy: a possible clue to optimize cancEr tReatment (G-DEFINER): study protocol of an observational prospective multicenter studyRosalba Miceli, Hanna Eriksson, Giuseppe Lo Russo, et al.
Cancers|September 20, 2019
Age-Related Alterations in Immune Contexture Are Associated with Aggressiveness in RhabdomyosarcomaPatrizia Gasparini, Orazio Fortunato, Loris De Cecco, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 10, 2024
Plasma-derived extracellular vesicles miR-335-5p as potential diagnostic biomarkers for fusion-positive rhabdomyosarcomaVirginia Di Paolo, Alessandro Paolini, Angela Galardi, et al.
Oncotarget|December 20, 2015
Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125bElisabetta Vergani, Lorenza Di Guardo, Matteo Dugo, et al.
The Journal of Investigative Dermatology|September 10, 2016
Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib TreatmentMarcella Tazzari, Valentina Indio, Barbara Vergani, et al.
Blood Advances|March 4, 2020
Integrative analysis of the genomic and transcriptomic landscape of double-refractory multiple myelomaBachisio Ziccheddu, Giulia Biancon, Filippo Bagnoli, et al.
Oncogene|September 21, 2004
Gene expression profiling of advanced ovarian cancer: characterization of a molecular signature involving fibroblast growth factor 2Loris De Cecco, Luigi Marchionni, Manuela Gariboldi, et al.
Cancers|April 15, 2020
Tumor Biomarkers for the Prediction of Distant Metastasis in Head and Neck Squamous Cell CarcinomaSalvatore Alfieri, Andrea Carenzo, Francesca Platini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2025
CINSARC and Sarculator in Patients with Primary Retroperitoneal Sarcoma: A Combined Analysis of Single-Institution Data and the EORTC-STBSG-62092 Trial (STRASS)Dario Callegaro, Gabriele Tinè, Felix Boakye Oppong, et al.
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
A clinicogenomic model including GARD predicts outcome for radiation treated patients with HPV+ oropharyngeal squamous cell carcinomaEmily Ho, Loris De Cecco, Stefano Cavalieri, et al.
Pageof 17

Showing results (131-140 of 169) with videos related to

Sort By:
Pageof 17
Acta Oncologica (Stockholm, Sweden)|April 22, 2024
Gender Difference in sidE eFfects of ImmuNotherapy: a possible clue to optimize cancEr tReatment (G-DEFINER): study protocol of an observational prospective multicenter studyRosalba Miceli, Hanna Eriksson, Giuseppe Lo Russo, et al.
Cancers|September 20, 2019
Age-Related Alterations in Immune Contexture Are Associated with Aggressiveness in RhabdomyosarcomaPatrizia Gasparini, Orazio Fortunato, Loris De Cecco, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 10, 2024
Plasma-derived extracellular vesicles miR-335-5p as potential diagnostic biomarkers for fusion-positive rhabdomyosarcomaVirginia Di Paolo, Alessandro Paolini, Angela Galardi, et al.
Oncotarget|December 20, 2015
Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125bElisabetta Vergani, Lorenza Di Guardo, Matteo Dugo, et al.
The Journal of Investigative Dermatology|September 10, 2016
Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib TreatmentMarcella Tazzari, Valentina Indio, Barbara Vergani, et al.
Blood Advances|March 4, 2020
Integrative analysis of the genomic and transcriptomic landscape of double-refractory multiple myelomaBachisio Ziccheddu, Giulia Biancon, Filippo Bagnoli, et al.
Oncogene|September 21, 2004
Gene expression profiling of advanced ovarian cancer: characterization of a molecular signature involving fibroblast growth factor 2Loris De Cecco, Luigi Marchionni, Manuela Gariboldi, et al.
Cancers|April 15, 2020
Tumor Biomarkers for the Prediction of Distant Metastasis in Head and Neck Squamous Cell CarcinomaSalvatore Alfieri, Andrea Carenzo, Francesca Platini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2025
CINSARC and Sarculator in Patients with Primary Retroperitoneal Sarcoma: A Combined Analysis of Single-Institution Data and the EORTC-STBSG-62092 Trial (STRASS)Dario Callegaro, Gabriele Tinè, Felix Boakye Oppong, et al.
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
A clinicogenomic model including GARD predicts outcome for radiation treated patients with HPV+ oropharyngeal squamous cell carcinomaEmily Ho, Loris De Cecco, Stefano Cavalieri, et al.
Pageof 17